Comparing planned versus ad hoc coronary microvascular assessment: Early findings from the Coronary Microvascular Disease Registry

被引:1
|
作者
Merdler, Ilan [1 ]
Bazarbashi, Nadjat [1 ]
Medranda, Giorgio A. [2 ]
Zhang, Cheng [1 ]
Ozturk, Sevket Tolga [1 ]
Sawant, Vaishnavi [1 ]
Ben-Dor, Itsik [1 ]
Waksman, Ron [1 ]
Hashim, Hayder D. [1 ]
Case, Brian C. [1 ]
机构
[1] MedStar Washington Hosp Ctr, Sect Intervent Cardiol, Washington, DC USA
[2] NYU Langone Hosp Long Isl, Div Cardiol, Mineola, NY USA
关键词
Coronary microvascular dysfunction; Stable angina; Chest pain; Hemodynamic assessment; Ischemia non-obstructive coronary artery; DYSFUNCTION; ISCHEMIA; WOMEN; HEART;
D O I
10.1016/j.carrev.2024.04.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Coronary microvascular dysfunction (CMD) is an etiology for angina with non-obstructive coronary disease. However, the initial adoption of CMD assessment, whether planned or conducted ad hoc, is limited. We characterize planned and ad hoc CMD assessments and highlight evolving trends of a CMD referral center. Methods: We analyzed outpatient data from the Coronary Microvascular Disease Registry from 2021 to 2023. Patients were categorized into planned or ad hoc CMD assessment groups, and baseline characteristics, hospital stay, medications, and physiological measurements were compared. Secondary analysis evaluated a CMD referral center's evolution. Results: Of 101 included outpatients, 67.3 % underwent ad hoc procedures and 32.7 % planned procedures. Average age was 63.1 +/- 10.1 years. The planned procedure group was 87.9% female, and the ad hoc procedure group was 51.5 % female. There were no significant differences in index of microvascular resistance or coronary flow reserve between groups. Hospital stay duration was <1 day for both groups, and neither reported complications. Ad hoc patients were more frequently prescribed aspirin before (64.7 % vs. 36.4 %, p = 0.007) and after the procedure (66.2 % vs. 39.4%, p = 0.01). CMD rates were higher for planned procedures (30.3 % vs. 10.3 %, p = 0.01). We observed that CMD referral centers have more planned procedures and a higher rate of positive results over time. Conclusion: CMD referral centers'planned procedures, and subsequent positive cases, increased over time. This emphasizes the importance of planned procedures, appropriate patient selection, and increased awareness of CMD among healthcare providers. Clinical trial registration: Coronary Microvascular Disease (CMD) Registry, NCT05960474, https://clinicaltrials.gov/ study/NCT05960474
引用
收藏
页码:69 / 74
页数:6
相关论文
共 50 条
  • [1] Comparing Planned Versus Ad Hoc Coronary Microvascular Assessment: Early Findings from the Coronary Microvascular Disease Registry
    Merdler, I.
    Bazarbashi, N.
    Zhang, C.
    Ozturk, S. T.
    Sawant, V.
    Ben-Dor, I.
    Hashim, H.
    Waksman, R.
    Case, B. C.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (04) : S48 - S48
  • [2] Coronary microvascular dysfunction and inflammation: Insights from the Coronary Microvascular Disease Registry
    Merdler, Ilan
    Chitturi, Kalyan R.
    Chaturvedi, Abhishek
    Li, Jason
    Cellamare, Matteo
    Ozturk, Sevket Tolga
    Sawant, Vaishnavi
    Ben-Dor, Itsik
    Waksman, Ron
    Case, Brian C.
    Hashim, Hayder D.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2024, 69 : 30 - 34
  • [3] Coronary Microvascular Dysfunction and Inflammation: Insights from the Coronary Microvascular Disease Registry
    Merdler, I.
    Case, B. C.
    Li, J.
    Wallace, R.
    Chitturi, K. R.
    Chaturvedi, A.
    Zhang, C.
    Cellamare, M.
    Sawant, V. S.
    Ben-Dor, I.
    Waksman, R.
    Hashim, H. D.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (04) : S48 - S49
  • [4] Understanding Patient Characteristics and Coronary Microvasculature: Early Insights from the Coronary Microvascular Disease Registry
    Case, Brian C.
    Merdler, Ilan
    Medranda, Giorgio A.
    Zhang, Cheng
    Ozturk, Sevket Tolga
    Sawant, Vaishnavi
    Margulies, Adrian D.
    Ben-Dor, Itsik
    Waksman, Ron
    Hashim, Hayder D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 205 : 97 - 103
  • [5] Coronary Microvascular Disease Registry (CMDR): Study design and rationale
    Case, Brian C.
    Merdler, Ilan
    Medranda, Giorgio A.
    Zhang, Cheng
    Ozturk, Sevket Tolga
    Sawant, Vaishnavi
    Garcia-Garcia, Hector M.
    Satler, Lowell F.
    Ben-Dor, Itsik
    Hashim, Hayder D.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2024, 66 : 63 - 67
  • [6] Coronary artery disease versus coronary microvascular disease: advanced analysis of magnetocardiographic maps
    Chaikovsky, Illya
    Mjasnikov, Georg
    Lutay, Michael
    Udovichenko, Eugen
    Popov, Anton
    Sofienko, Sergey
    Ji, Wenming
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C88 - C88
  • [7] Coronary Microvascular Function in Early Chronic Kidney Disease
    Charytan, David M.
    Shelbert, Heinrich R.
    Di Carli, Marcelo F.
    CIRCULATION-CARDIOVASCULAR IMAGING, 2010, 3 (06) : 663 - 671
  • [8] Understanding Patients' Characteristics and Coronary Microvasculature: Early Insights From First US Coronary Microvascular Dysfunction Registry
    Merdler, Ilan
    Case, Brian
    Medranda, Giorgio A.
    Ben-Dor, Itsik
    Waksman, Ron
    Hashim, Hayder
    CIRCULATION, 2023, 148
  • [9] Invasive assessment of the microvascular coronary circulation in patients with coronary artery aneurysmal disease
    Iwanczyk, Sylwia
    Smukowska-Gorynia, Anna
    Wozniak, Patrycja
    Grygier, Marek
    Lesiak, Maciej
    Araszkiewicz, Aleksander
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2023, 133 (01):
  • [10] Multimodality assessment of the coronary microvasculature with TIMI frame count versus perfusion PET highlights coronary changes characteristic of coronary microvascular disease
    Wayne, Nicole
    Wu, Qufei
    Moore, Stephen C.
    Ferrari, Victor A.
    Metzler, Scott D.
    Guerraty, Marie A.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11